Prevalence and characteristics of patients with pseudoakathisia

European Neuropsychopharmacology

Volumn 10, Issue 5, 2000, Pages 333-336

  Havaki Kontaxaki, B J ^a   Kontaxakis, V P ^a   Christodoulou, G N ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Parkinsonism; Prevalence; Pseudoakathisia; Tardive dyskinesia

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; THIORIDAZINE;

ADULT; AKATHISIA; ARTICLE; DOSE RESPONSE; DRUG POTENCY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSEUDOAKATHISIA; RATING SCALE;

EID: 0033838782     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(00)00090-0     Document Type: Article

References (25)

1. 4th Edition Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 1994;American Psychiatric Press, Washington DC.
2. Ayd F. A survey of drug-induced extrapyramidal reactions. J. Am. Med. Assoc. 175:1961;1054-1060.
3. Barnes T.R.E. A rating scale for drug-induced akathisia. Br. J. Psychiatry. 154:1989;672-676.
4. Barnes T.R.E., Braude W.M. Akathisia variants and tardive dyskinesia. Arch. Gen. Psychiatry. 42:1985;874-878.
5. Barnes T.R.E., Halstead S.M., Little P.W.A. Relationship between iron status and chronic akathisia in an in-patient population with chronic schizophrenia. Br. J. Psychiatry. 161:1992;791-796.
6. Braude W.M., Barnes T.R.E., Gore S.M. Clinical characteristics of akathisia: a systematic investigation of acute psychiatric inpatient admissions. Br. J. Psychiatry. 143:1983;139-150.
7. Brown K.W., White T. Pseudoakathisia and negative symptoms in schizophrenic subjects. Acta Psychiatr. Scand. 84:1991;107-109.
8. Halstead S.M., Barnes T.R., Speller J.C. Akathisia: prevalence and associated dysphoria in an in-patient population with chronic schizophrenia. Br. J. Psychiatry. 164:1994;173-183.
9. Haskovec L. Akathisie. Arch. Bohemes Med. Clin. 3:1902;193-200.
10. Johnson D.A.W., Wright N.F. Drug prescribing for schizophrenic out-patients on depot injections: repeat surveys over 18 years. Br. J. Psychiatry. 156:1990;827-834.
11. Kaplan H.I., Sadock B.J. Clinical Psychiatry from Synopsis of Psychiatry. 1988;Williams and Wilkins, Baltimore.
12. Klett C.J., Point P., Caffey E. Evaluating the long-term need for antiparkinson drugs by chronic schizophrenics. Arch. Gen. Psychiatry. 26:1972;375-377.
13. Kontaxakis V.P., Havaki-Kontaxaki B.J., Christodoulou G.N. Mortality of schizophrenic in-patients in Athens. Christodoulou G.N., Lecic-Tocevski D., Kontaxakis V.P. Issues in Preventive Psychiatry. 1999;88-92 Karger, Basel.
14. McCreadie R.G., Robertson L.J., Wiles D.H. The Nithsdale schizophrenia surveys: akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic levels. Br. J. Psychiatry. 161:1992;793-799.
15. Munetz M.R., Cornes C.L. Akathisia, pseudoakathisia and tardive dyskinesia: clinical examples. Compr. Psychiatry. 23:1982;345-352.
16. Norusis M.J. SPSS for Windows: Professional Statistics. 1993;SPSS, Chicago.
17. Sachdev P. Research diagnostic criteria for drug-induced akathisia: conceptualization, rationale and proposal. Psychopharmacology. 114:1994;181-186.
18. Sachdev P. The epidemiology of drug-induced akathisia: Part II. Chronic, tardive and withdrawal akathisias. Schizophr. Bull. 21:1995;451-461.
19. Sachdev P., Loneragan C. The present status of akathisia. J. Nerv. Ment. Dis. 179:1991;381-389.
20. Schooler N., Kane J.M. Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatry. 39:1982;486-487.
21. Simpson G.M., Angus J.W.S. A rating scale for extrapyramidal side effects. Acta Psychiatr. Scand. 212:(Suppl.):1970;11-19.
22. Steck H. Le syndrome extrapyramidal et diencephalique au cours des traitements au largactil et au serpasil. Ann. Medico-Psychologiques (Paris). 112:1954;734-744.
23. Abnormal involuntary movements scale (AIMS). Guy W. ECDEU Assessment Manual. 1976;534-537 US Department of Health, Education and Welfare, Rockville, MD.
24. Van Harten P.N., Matroos G.E., Heck H.W., Kahn R.S. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia. Schizophr. Res. 19:1996;195-203.
25. Van Putten T. Why do schizophrenic patients refuse to take their drugs? Arch. Gen. Psychiatry. 31:1974;67-72.